论文部分内容阅读
Our previous research demonstrated that paclitaxel-containing extract (HDS-1), derived from Taxus yunnanensis, improved the oral absorption of paclitaxel by 9.7 fold and have potential to develop its oral formulation, safer and sustainable therapy for curing cancer.